SCHEMBL25398627

SCHEMBL25398627

CCOC(=O)C1CC(CNC(=O)c2cc(C)on2)=NO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ MAPT P10636 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TSHR P16473 1/20 0.43
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ GAA P10253 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ LMNA P02545 3/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ AR P10275 1/20 0.38
▸ PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29846557 0.81 SMN1; SMN2 (0.47) CYP2C19CYP1A2ALDH1A1MEN1KMT2A
SCHEMBL25399160 0.81 HPGD (0.43) MAPTALDH1A1MEN1KMT2ATSHR
SCHEMBL25401359 0.81 SMN1; SMN2 (0.47) CYP2C19CYP1A2ALDH1A1MEN1KMT2A
SCHEMBL25402422 0.80 MEN1 (0.46) ALDH1A1MEN1KMT2ATSHRNPC1
SCHEMBL25399266 0.78 ALDH1A1 (0.44) ALDH1A1MEN1KMT2ATSHRTP53
SCHEMBL25400323 0.77 EPHX2 (0.46) CYP2C19CYP1A2MAPTALDH1A1MEN1
SCHEMBL25398628 0.77 LMNA (0.38) ALDH1A1MEN1KMT2ATSHRNPC1
SCHEMBL25402845 0.77 TSHR (0.42) CYP2C19CYP1A2ALDH1A1KMT2ATSHR
SCHEMBL25400119 0.77 P2RY12 (0.51) CYP2C19CYP1A2CYP2D6MAPTALDH1A1
SCHEMBL29846806 0.77 LMNA (0.38) ALDH1A1MEN1KMT2ATSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 — — US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 — — US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 CYP2C19 2008/4885CYP1A2 1381/4885CYP2D6 439/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 CYP2C19 2880/4885CYP1A2 2451/4885CYP2D6 1961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback